Cre-LoxP Mediated Induction of Cerebral Cavernous Malformations in a Mouse Model
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 1:59 min • July 8th, 2025
Loading...
Overview
This study investigates the role of the CCM2 gene in blood vessel stability using genetically modified mouse pups. The disruption of this gene leads to the formation of fragile vascular structures known as cerebral cavernous malformations (CCMs).
Key Study Components
Area of Science
- Neuroscience
- Genetics
- Vascular Biology
Background
- The CCM2 gene is crucial for maintaining endothelial cell integrity.
- Endothelial cells are vital for blood vessel stability.
- Cerebral cavernous malformations are associated with compromised vascular structures.
- Genetic modifications can elucidate the role of specific genes in vascular health.
Purpose of Study
- To explore the effects of CCM2 gene disruption on blood vessel stability.
- To understand the mechanisms leading to the formation of CCMs.
- To utilize genetically modified mice as a model for studying vascular malformations.
Methods Used
- Genetically modified mouse pups expressing the CCM2 gene flanked by loxP sites were used.
- Cre recombinase fused to an estrogen receptor was expressed in endothelial cells.
- 4-hydroxytamoxifen was intragastrically injected to activate Cre recombinase.
- The recombination event was induced to excise the CCM2 gene segment.
Main Results
- The loss of CCM2 resulted in compromised endothelial cell integrity.
- Fragile and abnormal vascular structures, or CCMs, developed in the modified mice.
- These structures were prone to leakage, indicating instability.
- The methodology effectively induced experimental CCM lesions in neonatal pups.
Conclusions
- CCM2 is essential for the stability of blood vessels.
- Disruption of this gene leads to significant vascular abnormalities.
- This model can be used for further research into vascular diseases.
Frequently Asked Questions
What is the significance of the CCM2 gene?
The CCM2 gene is crucial for maintaining the stability of blood vessels.
What are cerebral cavernous malformations?
CCMs are abnormal vascular structures that are fragile and prone to leakage.
How was the CCM2 gene disrupted in the study?
The gene was disrupted using Cre recombinase activated by 4-hydroxytamoxifen.
What animal model was used in this research?
Genetically modified mouse pups were used as the model organism.
What are the implications of this study?
The findings enhance understanding of vascular diseases and potential therapeutic targets.
How does the study contribute to neuroscience?
It provides insights into the genetic factors affecting vascular stability in the brain.
Executive Industry Relevance
This model enables mechanistic interrogation of vascular integrity genes in a disease-relevant system, supporting target validation for cerebral cavernous malformations. By inducing endothelial-specific gene deletion with temporal control, it provides a reproducible platform for preclinical de-risking of vascular stability targets. The approach aids in evaluating therapeutic hypotheses and prioritizing candidates with predictive confidence in neurovascular discovery pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of CCM2's role in endothelial integrity and blood vessel stability.
- Operational Value: Provides inducible, cell-type-specific gene deletion to establish causal links between genetic perturbation and vascular phenotype.
- Scientific Value: Supports target validation by modeling human CCM pathology through precise genetic disruption.
Screening & Assay Development
- Scientific Value: Generates disease-relevant vascular lesions for screening compounds that modulate vascular stability or leakage.
- Operational Value: Delivers quantifiable CCM burden via micro-CT imaging for assay readout standardization.
- Scientific Value: Enables evaluation of rescue phenotypes upon target re-expression or pharmacological intervention.
Translational & Preclinical Research
- Scientific Value: Models human CCM pathogenesis in a genetically defined system for preclinical target evaluation.
- Operational Value: Facilitates longitudinal monitoring of lesion development and progression in vivo.
- Scientific Value: Supports biomarker discovery by correlating genetic lesions with vascular dysfunction endpoints.
Pipeline & Workflow Integration
The model fits within the discovery continuum from target validation through preclinical assessment, enabling iterative testing of vascular stability mechanisms.
- Discovery Biology: Supports hypothesis testing of vascular integrity genes via inducible endothelial knockout.
- Screening: Provides reproducible lesion formation for compound screening in a disease-relevant context.
- Analytics: Delivers quantitative vascular lesion burden via imaging for comparative condition analysis.
- Translational Research: Connects genetic disruption to human-relevant vascular malformation phenotypes.
- Enterprise Reuse: Establishes a reusable platform for studying multiple vascular stability genes in the CCM pathway.
Operational & Enterprise Impact
- Scientific Value: Mechanistic de-risking of vascular targets through causal genetic modeling.
- Operational Value: Standardized induction protocol ensures reproducibility across laboratories and studies.
- Strategic Value: Informs go/no-go decisions by predicting vascular liability of targets early in discovery.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on vascular safety profiles.
Implementation Considerations
- Requires expertise in genetically engineered mouse models and inducible Cre-lox systems.
- Dependent on access to tamoxifen-inducible Cre lines and genotyping infrastructure.
- Necessitates standardized dosing and delivery of 4-hydroxytamoxifen for consistent induction.
- Requires micro-CT or histological validation to confirm CCM formation and burden.
- Limited to postnatal induction windows; may not model embryonic vascular developmental roles.
Biopharma FAQs
Why is inducible CCM2 deletion important for target validation?
Inducible, endothelial-specific deletion of CCM2 establishes causal gene-phenotype relationships in vascular integrity, enabling precise target validation in a disease-relevant model. This approach avoids developmental confounders and allows temporal control over lesion induction, supporting mechanistic de-risking of vascular targets.
How does isolating the independent variable (CCM2 loss) fit the discovery pipeline?
By isolating CCM2 loss as the independent variable through Cre-loxP recombination, the model enables unambiguous attribution of vascular phenotypes to a single genetic perturbation. This supports hypothesis-driven discovery and reduces noise in target validation workflows.
What quantitative dependent variable measurements enable CCM assessment?
Micro-CT imaging provides quantitative readouts of CCM lesion burden, size, and distribution, enabling objective comparison across experimental conditions. These measurements support assay standardization and data-driven go/no-go decisions in preclinical evaluation.
Why do replication requirements matter for cross-functional collaboration?
Standardized induction and imaging protocols ensure reproducible CCM formation across studies, facilitating data sharing and alignment between discovery, preclinical, and translational teams. Reproducibility builds confidence in target validation outcomes and supports multi-site validation efforts.
What statistical analysis capabilities are required before implementation?
Implementation requires statistical power analysis to determine appropriate cohort sizes for detecting significant differences in CCM burden between groups. Comparative analysis of lesion volume or count enables robust evaluation of genetic or pharmacological effects on vascular stability.
05:12
A Micro-CT-based Method for Characterizing Lesions and Locating Electrodes in Small Animal Brains
Related Videos
0 Views
03:58
Generation of Brown Fat-Specific Knockout Mice Using a Combined Cre-LoxP, CRISPR-Cas9, and Adeno-Associated Virus Single-Guide RNA System
Related Videos
0 Views
13:01
Intraluminal Middle Cerebral Artery Occlusion (MCAO) Model for Ischemic Stroke with Laser Doppler Flowmetry Guidance in Mice
Related Videos
0 Views
03:30
Targeted Drug Delivery in a Mouse Model via Cisterna Magna Injection
Related Videos
0 Views
03:35
Contrast-Enhanced Micro-CT Imaging of Cerebral Cavernous Malformation Lesions in a Mouse Brain
Related Videos
0 Views
07:08
A Mouse Model for Laser-induced Choroidal Neovascularization
Related Videos
0 Views
05:12
Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
Related Videos
0 Views
10:29
Inducing Cre-lox Recombination in Mouse Cerebral Cortex Through In Utero Electroporation
Related Videos
0 Views
05:55
Induction of Leptomeningeal Cells Modification Via Intracisternal Injection
Related Videos
0 Views
07:17
A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
Related Videos
0 Views
Last updated: 27 June 2026